[go: up one dir, main page]

MX2013009007A - Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas. - Google Patents

Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas.

Info

Publication number
MX2013009007A
MX2013009007A MX2013009007A MX2013009007A MX2013009007A MX 2013009007 A MX2013009007 A MX 2013009007A MX 2013009007 A MX2013009007 A MX 2013009007A MX 2013009007 A MX2013009007 A MX 2013009007A MX 2013009007 A MX2013009007 A MX 2013009007A
Authority
MX
Mexico
Prior art keywords
nutritional compositions
protein
omega
methods
make
Prior art date
Application number
MX2013009007A
Other languages
English (en)
Inventor
Norman Alan Greenberg
Doug Bolster
Zamzam Kabiry Fariba Roughead
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45554910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013009007(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013009007A publication Critical patent/MX2013009007A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se proporcionan composiciones nutricionales que tienen altas cantidades de proteínas y bajas relaciones de ácidos grasos omega-6:omega-3, y los métodos para preparar y usar las composiciones nutricionales. Las composiciones nutricionales incluyen una mayor cantidad de proteína, y una baja proporción de ácidos grasos omega-6:omega-3 para proporcionarle a un paciente las cantidades adecuadas de proteínas para la preservación de la masa corporal magra, y al mismo reducir la inflamación asociada con la administración de formulaciones de drogas proinflamatorias como el propofol. Las composiciones nutricionales también ayudan a evitar complicaciones potenciales, asociadas con la sobrealimentación de un paciente alimentado por vía enteral bajo tratamiento, o que haya sido tratado, con medicamentos con alto contenido de grasa como el propofol. También se proporcionan métodos para preparar y usar tales composiciones nutricionales.
MX2013009007A 2011-02-02 2012-01-26 Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas. MX2013009007A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161438804P 2011-02-02 2011-02-02
PCT/US2012/022726 WO2012106179A1 (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same

Publications (1)

Publication Number Publication Date
MX2013009007A true MX2013009007A (es) 2013-08-29

Family

ID=45554910

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013009007A MX2013009007A (es) 2011-02-02 2012-01-26 Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas.

Country Status (14)

Country Link
US (1) US9930908B2 (es)
EP (1) EP2670262B2 (es)
JP (1) JP6034805B2 (es)
CN (1) CN103347403B (es)
AU (3) AU2012212591A1 (es)
BR (1) BR112013019677B1 (es)
CA (1) CA2824591C (es)
ES (1) ES2882806T3 (es)
MX (1) MX2013009007A (es)
PH (1) PH12013501433A1 (es)
RU (1) RU2013140443A (es)
SG (1) SG191428A1 (es)
WO (1) WO2012106179A1 (es)
ZA (1) ZA201306543B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012106179A1 (en) 2011-02-02 2012-08-09 Nestec S.A. High protein nutritional compositions and methods of making and using same
NZ711956A (en) 2013-03-08 2018-06-29 Axiom Foods Inc Rice protein supplements
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
WO2015095570A2 (en) * 2013-12-19 2015-06-25 Abbott Laboratories Nutritional composition comprising hydrolyzed protein
CN105212042A (zh) * 2014-06-30 2016-01-06 罗汉斐 一种小麦发酵营养食品及其制作方法
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
US10806169B2 (en) 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
US20190374569A1 (en) * 2018-06-12 2019-12-12 Richard Laver Intact pea protein-based nutrient composition
KR20210021026A (ko) * 2018-06-14 2021-02-24 마아즈, 인코오포레이티드 암에 걸린 동물을 지원하기 위한 조성물
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
JP7682790B2 (ja) 2018-11-20 2025-05-26 フォンテラ コ－オペレイティブ グループ リミティド 乳製品およびプロセス
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
EP3934441A1 (en) * 2019-05-31 2022-01-12 Société des Produits Nestlé S.A. Mct-based nutrition blend for providing health benefits in animals
AR120346A1 (es) * 2019-10-31 2022-02-09 Idemitsu Kosan Co Agente para suprimir la resistencia a la insulina en rumiantes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140304A (en) * 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5714472A (en) 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
PT754001E (pt) 1994-04-01 2002-07-31 Abbott Lab Produto nutricional para tratamento da colite ulcerosa e sua utilizacao
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
EP1105096B1 (en) 1998-08-19 2003-10-29 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
US20040121044A1 (en) * 2001-03-14 2004-06-24 John Tiano Nutritional product with high protein, low carbohydrate content and good physical stability
AU2002254309B2 (en) 2001-03-20 2006-02-02 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
SE526943C2 (sv) 2002-08-26 2005-11-22 Indevex Ab Födoämneskompositionsprodukt
US20040225022A1 (en) 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US20060280776A1 (en) * 2003-09-02 2006-12-14 Masafumi Koide Diet food
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
EP1723951A1 (en) 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
CA2571742C (en) * 2004-07-01 2013-01-15 Nestec S.A. Canine osteoarthritis diet formulation
JP5574561B2 (ja) * 2004-09-22 2014-08-20 味の素株式会社 総合経腸栄養組成物
RU2385647C2 (ru) 2005-08-26 2010-04-10 Нестек С.А. Питание для пациентов, страдающих ожирением
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
CN101365350A (zh) 2006-01-09 2009-02-11 雀巢技术公司 应激患者的治疗
BRPI0621481A2 (pt) * 2006-03-23 2011-12-13 Nestec Sa suplemento nutricional de alta caloria
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
WO2010064714A1 (ja) 2008-12-05 2010-06-10 味の素株式会社 栄養組成物
WO2012106179A1 (en) 2011-02-02 2012-08-09 Nestec S.A. High protein nutritional compositions and methods of making and using same

Also Published As

Publication number Publication date
EP2670262B2 (en) 2025-10-15
WO2012106179A1 (en) 2012-08-09
JP6034805B2 (ja) 2016-11-30
JP2014505702A (ja) 2014-03-06
EP2670262B1 (en) 2021-06-30
US9930908B2 (en) 2018-04-03
ES2882806T3 (es) 2021-12-02
CN103347403B (zh) 2016-04-20
CA2824591C (en) 2019-02-05
AU2016201327A1 (en) 2016-03-17
AU2017225011A1 (en) 2017-09-28
RU2013140443A (ru) 2015-03-10
US20140308390A1 (en) 2014-10-16
BR112013019677B1 (pt) 2019-10-08
BR112013019677A2 (pt) 2017-03-21
PH12013501433A1 (en) 2013-09-09
CN103347403A (zh) 2013-10-09
AU2017225011B2 (en) 2019-07-18
ZA201306543B (en) 2015-03-25
SG191428A1 (en) 2013-08-30
AU2012212591A1 (en) 2013-07-25
CA2824591A1 (en) 2012-08-09
EP2670262A1 (en) 2013-12-11

Similar Documents

Publication Publication Date Title
MX2013009007A (es) Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas.
CO2021003893A2 (es) Formulaciones para mejorar la salud intestinal
CL2018002997A1 (es) Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción.
MX2021004999A (es) Administracion de butirato, beta-hidroxibutirato, cannabidiol y compuestos relacionaods en seres humanos.
DOP2014000159A (es) Composiciones enriquecidas con dpa de ácidos grasos omega 3 poliinsaturados en forma de ácido libre
PE20151864A1 (es) Composiciones nutricionales que contienen una fraccion enriquecida de lipido y usos del mismo
MX356184B (es) Fórmulación pediátrica sintética que comprende un probiótico.
EA201991289A1 (ru) Быстродействующие лекарственные соединения и пищевые добавки растительного происхождения
AR104835A1 (es) Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas
AR088205A1 (es) Composiciones nutricionales fitonutrientes
JP2014505702A5 (es)
NZ600167A (en) Concentrated therapeutic phospholipid compositions
AR097110A1 (es) Composiciones nutricionales que contienen una combinación sinérgica y usos de las mismas
AR105237A1 (es) Método y composiciones nutricionales que contienen fosfatidiletanolamina, esfingomielina y ácido docosahexaenoico
MX2019009952A (es) Formulaciones de evolocumab de baja viscosidad y alta concentracion y metodos de elaboracion de las mismas.
AR105144A1 (es) Composiciones nutricionales y métodos para promover el desarrollo cognitivo
PH12018500090A1 (en) Nutritional compositions and methods for promoting cognitive development
AR110060A1 (es) Composiciones nutricionales que proporcionan el manejo dietético de cólicos
AR100313A1 (es) Composiciones nutricionales dirigidas a sujetos con alergias a la proteína de la leche de vaca
CL2018003537A1 (es) Lípidos con un número impar de átomos de carbono y su uso como una composición farmacéutica o como un suplemento nutricional.
MX2016000187A (es) Composiciones y metodos para mejorar el rendimiento del ejercicio.
CO7310519A2 (es) Enriquecedor para un sucedáneo de la leche materna
AR096564A1 (es) Composiciones nutricionales para bebés prematuros
PE20141192A1 (es) Metodo para la inhibicion de patogenos usando una composicion nutricional
AR095335A1 (es) Método para reducción del riesgo de enfermedad autoinmune

Legal Events

Date Code Title Description
FA Abandonment or withdrawal